Polysaccharide-modified scaffolds for controlled lentivirus delivery in vitro and after spinal cord injury

Journal of Controlled Release

Volumn 170, Issue 3, 2013, Pages 421-429

  Thomas, Aline M ^a   Shea, Lonnie D ^a,b,c  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Gene delivery; Lentivirus; Multiple channel bridge; Polysaccharide; Scaffold; Spinal cord injury

Indexed keywords

CHITIN; CHITOSAN; EFFICIENCY; GENE TRANSFER; GENES; HYALURONIC ACID; PATIENT REHABILITATION; POLYSACCHARIDES; SCAFFOLDS; SURFACE TREATMENT; TISSUE REGENERATION; VIRUSES;

CELLULAR MICROENVIRONMENT; GENE DELIVERY; LENTIVIRUS; MULTIPLE CHANNELS; POLY LACTIDE-CO-GLYCOLIDE; REGENERATIVE MEDICINE; SPINAL CORD INJURIES (SCI); TRANSDUCTION EFFICIENCY;

BACTERIOPHAGES;

CHITOSAN; HEPARIN; HYALURONIC ACID; LENTIVIRUS VECTOR; MOLECULAR SCAFFOLD; POLYGLACTIN; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CELL COUNT; COLORIMETRY; CONJUGATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; FEMALE; GENE EXPRESSION; IMPLANTATION; IN VITRO STUDY; LENTIVIRINAE; MOLECULAR WEIGHT; MOUSE; MYELINATION; NERVE FIBER; NERVE FIBER GROWTH; NEURITE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPINAL CORD INJURY; SURFACE PROPERTY;

GENE DELIVERY; LENTIVIRUS; MULTIPLE CHANNEL BRIDGE; POLYSACCHARIDE; SCAFFOLD; SPINAL CORD INJURY;

ANIMALS; CHITOSAN; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HEK293 CELLS; HEPARIN; HUMANS; HYALURONIC ACID; LACTIC ACID; LENTIVIRUS; LUCIFERASES; MICE; MICE, INBRED C57BL; POLYGLYCOLIC ACID; SPINAL CORD INJURIES; TISSUE SCAFFOLDS;

EID: 84885113852     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.06.013     Document Type: Article

References (50)

1. K. Kadoya, S. Tsukada, P. Lu, G. Coppola, D. Geschwind, M.T. Filbin, A. Blesch, M.H. Tuszynski, Combined intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration one year after spinal cord injury, Neuron 64 (2009) 165-172.
2. H.M. Tuinstra, M.O. Aviles, S. Shin, S.J. Holland, M.L. Zelivyanskaya, A.G. Fast, S.Y. Ko, D.J. Margul, A.-K. Bartels, R.M. Boehler, B.J. Cummings, A.J. Anderson, LD. Shea, Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury, Biomaterials 33 (2012) 1618-1626.
3. M.E. Kidd, S. Shin, LD. Shea, Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo, J. Control. Release 157 (2012) 80-85.
4. S. Shin, D.M. Salvay, LD. Shea, Lentivirus delivery by adsorption to tissue engineering scaffolds, J. Biomed. Mater. Res. A 93 (2010) 1252-1259.
5. S. Shin, H.M. Tuinstra, D.M. Salvay, L.D. Shea, Phosphatidylserine immobilization of lentivirus for localized gene transfer, Biomaterials 31 (2010) 4353-4359.
6. S. Shin, L.D. Shea, Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels, Mol. Ther. 18 (2010) 700-706.
7. M.O. Aviles, L.D. Shea, Hydrogels to modulate lentivirus delivery in vivo from microporous tissue engineering scaffolds, Drug Deliv. Transl. Res. 1 (2011) 91-101.
8. A. Jiang, T.H. Chu, F. Nocken, K. Cichutek, R. Dornburg, Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies, J. Virol. 72 (1998) 10148-10156. (Pubitemid 28520885)
9. F. Martin, S. Chowdhury, S.J. Neil, KA Chester, F.L. Cosset, M.K. Collins, Targeted retroviral infection of tumor cells by receptor cooperation, J. Virol. 77 (2003) 2753-2756. (Pubitemid 36222801)
10. T.J. Gollan, M.R. Green, Redirecting retroviral tropism by insertion of short, nondisruptive peptide ligands into envelope, J. Virol. 76 (2002) 3558-3563. (Pubitemid 34224557)
11. G. Rohman, S.C. Baker, J. Southgate, N.R. Cameron, Heparin functionalisation of porous PLGA scaffolds for controlled, biologically relevant delivery of growth factors for soft tissue engineering, J. Mater. Chem. 19 (2009) 9265-9273.
12. H. Shen, X. Hu, F. Yang, J. Bei, S. Wang, Cell affinity for bFGF immobilized heparin-containingpoly(lactide-co-glycolide) scaffolds, Biomaterials 32 (2011) 3404-3412.
13. M.N.V. Ravi Kumar, U. Bakowsky, CM. Lehr, Preparation and characterization of cationic PLGA nanospheres as DNA carriers, Biomaterials 5 (2004) 1771-1777. (Pubitemid 38102253)
14. Y.-I. Chung, J.C. Kim, Y.H. Kim, G. Tae, S.-Y. Lee, K. Kim, I.C. Kwon, The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting, J. Control. Release 143 (2010) 374-382.
15. H. Yamamoto, Y. Kuno, S. Sugimoto, H. Takeuchi, Y. Kawashima, Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions, J. Control. Release 102 (2005) 373-381. (Pubitemid 40093760)
16. Y.-C. Wu, S.-Y. Shaw, H.-R. Lin, T.-M. Lee, C.-Y. Yang, Bone tissue engineering evaluation based on rat calvaria stromal cells cultured on modified PLGA scaffolds, Biomaterials 27 (2006) 896-904. (Pubitemid 41484122)
17. E.L. Hedberg, C.K. Shih, L.A. Solchaga, A.I. Caplan, A.G. Mikos, Controlled release of hyaluronan oligomers from biodegradable polymeric microparticle carriers, J. Control. Release 100 (2004) 257-266. (Pubitemid 39491277)
18. A.K. Yadav, P. Mishra, A.K. Mishra, P. Mishra, S. Jain, G.P. Angrawal, Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin, Nanomedicine 3 (2007) 246-257. (Pubitemid 350199644)
19. H.S. Yoo, E.A. Lee, J.J. Yoon, T.G. Park, Hyaluronic acid modified biodegradable scaffolds for cartilage tissue engineering, Biomaterials 26 (2005) 1925-1933. (Pubitemid 39575334)
20. M.M. Segura, A. Garnier, Y. Durocher, H. Coelho, A. Karmen, Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification, Biotechnol. Bioeng. 98 (2007) 789-799. (Pubitemid 350032683)
21. A.M. Thomas, M.B. Kubilius, S.J. Holland, S.K. Seidlits, R.M. Boehler, A.J. Anderson, B.J. Cummings, L.D. Shea, Bridges with high channel density, porosity for enhancing axon growth after injury, Biomaterials 34 (2013) 2213-2220.
22. H.-C. Selinka, T. Giroglou, T. Nowak, N.D. Christensen, M. Sapp, Further evidence that papillomavirus capsids exist in two distinct conformations, J. Virol. 77 (2003) 12961-12967. (Pubitemid 37494291)
23. P.K. Smith, A.K. Mallia, G.T. Hermanson, Colorimetric method for the assay of heparin content in immobilized heparin preparations, Anal. Biochem. 109 (1980) 466-473. (Pubitemid 11101298)
24. P. Whiteman, The quantitative measurement of alcian blue- glycosaminoglycan complexes, Biochem. J. 131 (1973) 343-350.
25. G.G. Maghami, G.A.F. Roberts, Studies on the adsorption of anionic dyes on chitosan, Macromol. Chem. Phys. 189 (1988) 2239-2243.
26. Y. Yang, L. De Laporte, M.L. Zelivyanskaya, K.J. Whittlesey, A.J. Anderson, B.J. Cummings, L.D. Shea, Multiple channel bridges for spinal cord injury: cellular characterization of host response, Tissue Eng. Part A 25 (2009) 3283-3295.
27. M.S. Weiss, B.P. Bernabé, A.D. Bellis, L.J. Broadbelt, J.S. Jeruss, L.D. Shea, Dynamic, large-scale profiling of transcription factor activity from live cells in 3D culture, PLoS One 5 (2010) e14026.
28. S.C. Alter, D.D. Metccalfe, T.R. Bradford, L.B. Schwartz, Regulatin of human mast cell tryptase, Biochem. J. 348 (1987) 821-827.
29. S. Boddohi, N. Moore, P.A. Johnson, M.J. Kipper, Polysaccharide-based polyelectrolyte complex nanoparticles from chitosan, heparin, and hyaluronan, Biomacromolecules 10 (2009) 1402-1409.
30. S. Singh, B.M. Wu, J.C.Y. Dunn, The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds with surface cross-linked heparin, Biomaterials 32 (2011) 2059-2069.
31. J. Lee, J.J. Yoo, A. Atala, S.J. Lee, Controlled heparin conjugation on electrospun poly(ε-caprolactone) fibers for morphology-dependent protein delivery and enhanced cellular affinity, Acta Biomater. 8 (2012) 2549-2558.
32. F. Higashikawa, L.-J. Chang, Kinetic analyses of stability of simple and complex retoviral vectors, J. Virol. 280 (2001) 124-131. (Pubitemid 34158058)
33. G. Zhu, M.F. Mehler, J. Zhao, S. Yu Yung, J.A. Kessler, Sonic hedgehog and BMP2 exert opposing actions on proliferation and differentiation of embryonic neural progenitor cells, Dev. Biol. 215 (1) (1999) 118-129, (11/1/). (Pubitemid 29519807)
34. K. Lai, B.K. Kaspar, F.H. Gage, D.V. Schaffer, Sonic hedgehog regulates adult neural progenitor proliferationin vitro and in vivo, Nat. Neurosci. 6 (1) (2003) 21-27, (01//print). (Pubitemid 36026328)
35. G.L. Buchschacher Jr., F. Wong-Staal, Development of lentiviral vectors for gene therapy for humans diseases, Blood 95 (2000) 2499-2504. (Pubitemid 30210526)
36. T.I. Croll, A.J. O'Connor, G.W. Stevens, J.J. Cooper-White, Controllable surface modification of poly(lactic-co-glycolic acid) (PLGA) by hydrolysis or aminolysis I: physical, chemical, and theoretical aspects, Biomacromolecules 5 (2004) 463-473. (Pubitemid 38404482)
37. H. Hanenberg, X.L. Xiao, D. Dilloo, K. Hashino, I. Kato, D.A. Williams, Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells, Nat. Med. 2 (1996) 876-882. (Pubitemid 26296757)
38. S.D. Raut, P. Lei, R.M. Padmashali, S.T. Andreadis, Fibrin-mediated lentivirus gene transfer: implications for lentivirus microarrays, J. Control. Release 4 (2010) 213-220.
39. V. Baekelandt, A. Claeys, K. Eggermont, E. Lauwers, B. De Strooper, B. Nuttin, Z. Debyser, Characterization of lentiviral vector-mediated gene transfer in adult mouse brain, Hum. Gene Ther. 13 (2002) 841-853. (Pubitemid 34493977)
40. H.J. Lee, Y.S. Lee, H.S. Kim, Y.K. Kim, J.H. Kim, S.H. Jeon, H.W. Lee, S. Kim, H. Miyoshi, H.M. Chung, D.K. Kim, Retronectin enhances lentivirus-mediated gene delivery into hematopoietic progenitor cells, Biologicals 37 (2009) 203-209.
41. P. Lei, B. Bajaj, S.T. Andreadis, Retrovirus-associated heparin sulfate mediates immobilization and gene transfer on recombinant fibronectin, J. Virol. 76 (2002) 8722-8728. (Pubitemid 34864067)
42. C. Aiken, Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for nef and the sensitivity to cyclosporin A, J. Virol. 71 (1997) 5871-5877. (Pubitemid 27304923)
43. X. Sun, V.K. Yau, B.J. Briggs, G.R. Whittaker, Role of clathrn-mediated endocytosis during vesicular somatitis virus entry into host cells, J. Virol. 338 (2005) 53-60. (Pubitemid 40835926)
44. G.H. Guibinga, A. Miyanohara, J.D. Esko, T. Friedman, Cell surface heparin sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-g pseudotyped MLV-derived retrovirus vectors to target cells, Mol. Ther. 5 (2002) 538-546. (Pubitemid 34546083)
45. A. Basu, T. Kanda, A. Beyene, K. Saito, K. Meyer,R. Ray, Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells, J. Virol. 81 (2007) 3933-3941. (Pubitemid 46586889)
46. E. Copreni, S. Castellani, L. Palmieri, M. Penzo, M. Conese, Involvement of glycosaminoglycans in vesicular stomatitis virus G glycoprotein pseudotyped lentiviral vector-mediated gene transfer into airway epithelial cells, J. Gene Med. 10 (2008) 1294-1302.
47. D.S.W. Benoit, K.S. Anseth, Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation, Acta Biomater. 1 (2005) 461-470. (Pubitemid 43348782)
48. A. Zhu, M. Zhang, J. Wu, J. Shen, Covalent immobilization of chitosan/heparin complex with a photosensitive hetero-bifunctional crosslinking, Biomaterials 23 (2002) 4657-4665. (Pubitemid 36151618)
49. L. Schnell, S. Fearn, H. Klassen, M.E. Schwab, V.H. Perry, Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord, Eur. J. Neurosci. 11 (1999) 3648-3658. (Pubitemid 29484261)
50. K.D. Beck, H.X. Nguyen, M.D. Galvan, D.L. Salazar, T.M. Woodruff, A.J. Anderson, Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment, Brain 133 (2010) 433-447.